American Airlines on Thursday said it received an unsolicited notice from Qatar Airways.Read More »
A key issue for the Federal Trade Commission as it wraps up its investigation of Walgreens (WBA) bid for Rite Aid (RAD) is whether preferred pharmacy networks, like an exclusive arrangement Humana (HUM) has with Walmart (WMT) , are viable competitors to broad networks that include all the major pharmacy chains. Rite Aid shares fell 3.4%, or 11 cents, by Wednesday's close to $3.16. Humana argues that the information the FTC has requested is either irrelevant to the Rite Aid merger review or is available from the Centers for Medicare & Medicaid Services, the regulator of Medicare. "Walgreens proposed acquisition of Rite Aid could tip the balance in these reimbursement rate negotiations in its favor, allowing it to command higher reimbursement rates," the FTC said in its petition.
On Memorial Day weekend I joined my daughter in running the Buffalo Marathon. No, I didn’t run the 26 miles—they offer a half-marathon (13.2 miles) for those of us not quite up to the full. I started the race with a goal of finishing in two hours and
Oil is falling again today--and taking energy stocks down with it. And it doesn't help that analysts have been cutting oil stocks hand over fist, with one slashing his rating on 51 stocks this morning. Illustration: Agence France-Presse/Getty Images Barclays joined the cutting party this morning by dropping its rating on Schlumberger (SLB) to Equal Weight from Overweight. That might not seem to strange. But Barclays analyst J. David Anderson and team write that they "believe large caps still have the best risk/reward profile" in oil services and left their ratings on Halliburton (HAL) and Baker Hughes (BHI) unchanged at Overweight. So what's wrong with Schlumberger? I'll let Anderson explain: